October 2025 – Page 4

No Recent News on BridgeBio’s Thyroid Disorder Phase 3 Win

2 months ago talkbio0Tagged BridgeBio, Infrequent, Phase 3, Thyroid Diseases

BridgeBio; Phase 3; Rare Diseases; Thyroid Disorder

Step Pharma Appoints Dr. Karen L. Smith as Chief Medical Officer

2 months ago talkbio0Tagged Biological Factors, Chief Medical Officer, Clinical Development, CTPS1 inhibitor, dencatistat, Karen Smith, Neoplasms, Regulatory Affairs, Step Pharma

Step Pharma; Karen Smith; Chief Medical Officer; CTPS1 inhibitor; dencatistat; oncology; clinical development; biopharmaceutical; regulatory affairs

Jazz Pharmaceuticals Appoints Dr. Ted Love to Board of Directors

2 months ago talkbio0Tagged Audit Committee, Board appointment, board of directors, Corporate governance, Jazz, Kenneth W. O’Keefe, Retirement, Science, Ted Love

Jazz Pharmaceuticals; Ted Love; Board appointment; Board of Directors; Corporate governance; Audit Committee; Science and Medicine Committee; Kenneth W. O’Keefe retirement

Merck & Co.’s Welireg Notches Wins in Kidney Cancer Combo Studies

2 months ago talkbio0Tagged adjuvant setting, Combined Modality Therapy, Disease-Free Survival, Keytruda, Lenvima, Malignant neoplasm of kidney, Phase 3 trials, Progression-Free Survival, Renal Cell Carcinoma, Welireg

Welireg; kidney cancer; renal cell carcinoma; Keytruda; Lenvima; adjuvant setting; combination therapy; Phase 3 trials; progression-free survival; disease-free survival

Cigna Announces End to Drug Rebates for Many Health Plans Beginning in 2027

2 months ago talkbio0Tagged brand-name prescriptions, Cigna, drug price, drug rebates, Evernorth, Express Scripts, manager, Pharmaceutical Services, pharmacy reimbursement, Trump administration, upfront discounts

Cigna; drug rebates; pharmacy benefit manager; Evernorth; Express Scripts; upfront discounts; brand-name prescriptions; pharmacy reimbursement; Trump administration; drug pricing

Expert Insights to Navigate Your CGT Challenges: Recent Updates and Strategic Guidance for 2025

2 months ago talkbio0Tagged calcium glucarate, Capital, Challenge, Changing, Cognitive function: planning, gains, Investments, Long-term, minimization, Private Equity, rates, Taxes

capital gains tax; CGT challenges; 2025 tax rates; long-term capital gains; tax planning; tax minimization strategies; Net Investment Income Tax; private equity tax changes

BridgeBio Shifts Filing Plans After Phase 3 Success in Rare Disease Drug BBP-418

2 months ago talkbio0Tagged Acoramidis, Approved, BBP-418, Biological Markers, BridgeBio, commercial, disease drug, File (record), Infrequent, Limb-girdle muscular dystrophy type 2A, NDA, New Drug Application, Phase 3 success, Ribitol, United States Food and Drug Administration

BridgeBio; BBP-418; Phase 3 success; limb-girdle muscular dystrophy type 2I/R9; FDA filing; rare disease drug; NDA (New Drug Application); ribitol; full approval; biomarker; acoramidis; commercial strategy

Intellia Pauses Two CRISPR Trials After Severe Liver Toxicity Hospitalizes Patient

2 months ago talkbio0Tagged Clustered Regularly Interspaced Short Palindromic Repeats, Gene Modification, Hospitalization, Intellia, Liver, Pauses, Phase 3 Clinical Trials, Safety, Senile cardiac amyloidosis, Toxicity aspects

Intellia Therapeutics; CRISPR; transthyretin amyloidosis; Phase III trials; gene editing; liver toxicity; patient hospitalization; safety pause

Clearmind Medicine Appoints Mary-Elizabeth Gifford as Chief of Global Impact

2 months ago talkbio0Tagged Clearmind Medicine, Clinical Trials, governmental engagement, Mary-Elizabeth, mental health, partnerships, psychedelic medicine, regulatory advocacy, U.S.

Clearmind Medicine; Mary-Elizabeth Gifford; Chief of Global Impact; psychedelic medicine; US partnerships; governmental engagement; regulatory advocacy; biotech company; clinical trials; mental health

OpenAI Collaborates with Thermo Fisher and Lundbeck to Enhance Pharma Research

2 months ago talkbio0Tagged DNA Integration, Lundbeck, OpenAI, Pharma, Thermo Fisher

OpenAI; Thermo Fisher; Lundbeck; Pharma; AI Integration